Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease

Schizophrenia Bulletin

Volumn 40, Issue SUPPL. 4, 2014, Pages

  Waters, Flavie ^a,b   Collerton, Daniel ^c   Ffytche, Dominic H ^d   Jardri, Renaud ^e   Pins, Delphine ^e   Dudley, Robert ^c,f   Blom, Jan Dirk ^g,h   Mosimann, Urs Peter ⁱ   Eperjesi, Frank ^j   Ford, Stephen ^k   Laroi, Frank ^l  

^a GRAYLANDS HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIV LILLE   (France)

^f TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^g PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j ASTON UNIVERSITY   (United Kingdom)

^k SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^l UNIVERSITY OF LIÈGE   (Belgium)

more..

Author keywords

cognition; imaging; psychosis; schizophrenia; visual hallucinations

Indexed keywords

AFFECTIVE PSYCHOSIS; AGE DISTRIBUTION; ARTICLE; AUDITORY HALLUCINATION; BRAIN ELECTROPHYSIOLOGY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITION; COGNITIVE THERAPY; COMMUNITY; COMMUNITY LIVING; COMPARATIVE STUDY; CONTENT ANALYSIS; DISEASE ASSOCIATION; EYE DISEASE; HEALTH BELIEF; HUMAN; KNOWLEDGE BASE; MENTAL DISEASE; NERVE DEGENERATION; NEUROIMAGING; OUTCOME ASSESSMENT; PERCEPTION; PERCEPTION DISORDER; PHARMACEUTICAL CARE; PHENOMENOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REALITY THERAPY; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SELF CONTROL; SELF EVALUATION; SEX RATIO; TEMPORAL ANALYSIS; VISUAL CORTEX; VISUAL HALLUCINATION; BRAIN; DEGENERATIVE DISEASE; HALLUCINATIONS; PATHOPHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

AFFECTIVE DISORDERS, PSYCHOTIC; BRAIN; EYE DISEASES; HALLUCINATIONS; HUMANS; NEURODEGENERATIVE DISEASES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; VISUAL CORTEX;

EID: 84902587275     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu036     Document Type: Article

References (114)

1. Macpherson F. The philosophy and psychology of hallucination: an introduction. In: Macpherson F, Platchias D, eds. Hallucination: Philosophy and Psychology. Cambridge, MA: MIT Press; 2013.
2. Bleuler E. Textbook of Psychiatry. Eds Brill. New York: Macmillan; 1924.
3. Waters F, Woods A, Fernyhough C. Report on the 2nd International Consortium on Hallucination Research (ICHR): evolving directions and top 10 'hot spot' in hallucination research. Schizophr Bull. 2014;40: 24-27. doi: 10.1093/schbul/sbt167
4. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl. 1992;20:1-97.
5. Bowman K, Raymond A. A statistical study of delusions in the manic-depressive psychoses. Am J Psychiatry. 1931-1932;88:111-121.
6. Goodwin F, Jamison K. Manic Depressive Illness. Oxford: Oxford Press; 1999.
7. Feinberg I. A comparison of the visual hallucinations in schizophrenia with those induced by mescaline and LSD-25. Hallucinations. 1962:64-76.
8. Malitz S, Wilkins B, Esecover H. A comparison of drug-induced hallucinations with those seen in spontaneously occurring psychosis. In: West LJ, ed. Hallucinations. New York, NY: Grune & Stratton; 1962.
9. Vitols MM, Waters HG, Keeler MH. Hallucinations and delusions in white and negro schizophrenics. Am J Psychiatry. 1963;120:472-476.
10. Goldberg SC, Klerman GL, Cole JO. Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment. Br J Psychiatry. 1965;111:120-133.
11. Mott RH, Small IF, Anderson JM. Comparative study of hallucinations. Arch Gen Psychiatry. 1965;12:595-601.
12. Small IF, Small JG, Andersen JM. Clinical characteristics of hallucinations of schizophrenia. Dis Nerv Syst. 1966;27:349-353.
13. Chapman J. The early symptoms of schizophrenia. Br J Psychiatry. 1966;112:225-251.
14. Holmboe R, Astrup C. A follow-up study of 255 patients with acute schizophrenia and schizophreniform psychoses. Acta Psychiatr Scand Suppl. 1957;115:9-61.
15. Jansson B. The prognostic signifcance of various types of hallucinations in young people. Acta Psychiatr Scand. 1968;44:401-409.
16. Goodwin D W, Alderson P, Rosenthal R. Clinical signifcance of hallucinations in psychiatric disorders. A study of 116 hallucinatory patients. Arch Gen Psychiatry. 1971;24:76-80.
17. Eggers C. Verlaufsweisen Kindlicher and Praepuberaler Schizophrenien. Monographie aus dem Gesamtgebiet der Psychiatrye V. Berlin, Germany: Springer Verlag.
18. McCabe MS, Fowler RC, Cadoret RJ, Winokur G. Symptom differences in schizophrenia with good and poor prognosis. Am J Psychiatry. 1972;128:1239-1243.
19. Young B. A phenomenological comparison of LSD and schizophrenic states. Br J Psychiatry. 1974;124:64-74.
20. Zarroug E. The frequency of visual hallucinations in schizophrenic patients in Saudi Arabia. Br J Psychiatry. 1975;127:55-63.
21. Ciompi L, Müller C. Lebensweg und Alter der Schizophrenen. Berlin, Germany: Springer; 1976.
22. Deiker T, Chambers HE. Structure and content of hallucinations in alcohol withdrawal and functional psychosis. J Stud Alcohol. 1978:39:1831-1840.
23. Huber G, Gross G, Schüttler R. Schizophrenie. Eine verlaufsund sozialpsychiatrische Langzeitstudie. Berlin, Germany: Springer; 1979.
24. Ndetei DM, Singh A. Hallucinations in Kenyan schizophrenic patients. Acta Psychiatr Scand. 1983;67:144-147.
25. Ndetei D, Vadher A. A cross-cultural study of the frequencies of Schneider's frst rank symptoms of schizophrenia. Acta Psychiatr Scand. 1984;70:540-544.
26. Winokur G, Scharfetter C, Angst J. The diagnostic value in assessing mood congruence in delusions and hallucinations and their relationship to the affective state. Eur Arch Psychiatry Neurol Sci. 1985;234:299-302.
27. Phillipson O, Harris J. Hallucinations in schizophrenia. Acta Psychiatr Scand. 1985;82:26-29.
28. Bracha HS, Wolkowitz OM, Lohr JB, Karson CN, Bigelow LB. High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry. 1989;146:526-528.
29. Owens RG, Slade PD, Fielding DM. Methods: patient series and quasi-experimental designs. In: Parry G, Watts FN, eds. Behavioural and Mental Health Research: A Handbook of Skills and Methods. Hove, UK: Lawrence Erlbaum Associates; 1989:189-210.
30. Mueser KT, Bellack AS, Brady EU. Hallucinations in schizophrenia. Acta Psychiatr Scand. 1990;82:26-29.
31. Bauer SM, Schanda H, Karakula H, et al. Culture and the prevalence of hallucinations in schizophrenia. Compr Psychiatry. 2011;52:319-325.
32. Rosenthal S. Changes in a population of hospitalised patients with affective disorders 1945-1965. Am J Psychiatry. 1966;123:671-681.
33. Taylor M, Abrams R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry. 1973;29:520-522.
34. Rosenthal NE, Rosenthal LN, Stallone F, Dunner DL, Fieve RR. Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry. 1980;37:804-810.
35. Black DW, Nasrallah A. Hallucinations and delusions in 1, 715 patients with unipolar and bipolar affective disorders. Psychopathology. 1988;22:28-34.
36. Keck PE Jr, McElroy SL, Havens JR, et al. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry. 2003;44:263-269.
37. Baethge C, Baldessarini R, Freudenthal K, Streeruwitz A. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipol Disord. 2005;7:136-145.
38. Tillman R, Geller B, Klages T, Corrigan M, Bolhofner K, Zimerman B. Psychotic phenomena in 257 young children and adolescents with bipolar I disorder: delusions and hallucinations (benign and pathological). Bipolar Disord. 2008;10:45-55.
39. Eaton W W, Romanoski A, Anthony JC, Nestadt G. Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis. 1991;179:689-693.
40. Tien AY. Distributions of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol. 1991;26:287-292.
41. Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res. 2000;97:153-164.
42. Waters FAV, Badcock JC, Maybery MT. Revision of the factor structure of the Launay-Slade Hallucination Scale (LSHS-R). Pers Individ Dif. 2003;35:1351-1357.
43. Laroi F, Van der Linden M. Non-clinical participants reports of hallucinatory experiences. Can J Behav Sci. 2003;37:33-43.
44. Kessler RC, Birnbaum H, Demler O, et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry. 2005;58:668-676.
45. Van Os J, Hanssen M, Bijl RV. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res. 2000;45:11-20.
46. Núñez L, Gurpegui M. Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia. J Clin Psychiatry. 2002;63:812-816.
47. Mitchell J, Vierkant AD. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study. J Psychol. 1991;125:301-310.
48. Williams DR, Warren JD, Lees AJ. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry. 1998;1979:652-655.
49. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain. 2000;123 (Pt 4):733-745.
50. Schadlu AP, Schadlu R, Shepherd JB 3rd. Charles Bonnet syndrome: a review. Curr Opin Ophthalmol. 2009;20:219-222.
51. Ffytche DH. Visual hallucinations in eye disease. Curr Opin Neurol. 2009;22:28-35.
52. Lindal E, Stefansson G, Stefansson S. The qualitative difference of visions and visual hallucinations: a comparison of a general-population sample and clinical sample. Compr Psychiatry. 1994;35:405-408.
53. Lowe GR. The phenomenology of hallucinations as an aid to differential diagnosis. Br J Psychiatry. 1973;123:621-633.
54. Larøi F, DeFruyt F, van Os J, Aleman A, Van der Linden M. Associations between hallucinations and personality structure in a non-clinical sample: comparison between young and elderly samples. Pe rs Individ Diff. 2005;39:189-200.
55. Osis K, Haraldsson E. At the Hour of Death. New York, NY: Avon Books; 1977.
56. Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC. The life course of schizophrenia: age and symptom dimensions. Schizophr Res. 1997;23:15-23.
57. Oorschot M, Lataster T, Thewissen V, Wichers M, Myin-Germeys I. Mobile assessment in schizophrenia: a data-driven momentary approach. Schizophr Bull. 2012;38:405-413.
58. Morrison AP, Wells A, Nothard S. Cognitive factors in predisposition to auditory and visual hallucinations. Br J Clin Psychol. 2000;39 (Pt 1):67-78.
59. Rees W. The hallucinations of widowhood. Br Med J. 1971;4:37-38.
60. Forsell Y. Predictors for depression, anxiety and psychotic symptoms in a very elderly population: data from a 3-year follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2000;35:259-263.
61. Forsell Y, Henderson A. Epidemiology of paranoid symptoms in an elderly population. Br J Psychiatry. 1988:172;419-432.
62. Frieske DA, Wilson WP. Formal qualities of hallucinations: a comparative study of the visual hallucinations in patients with schizophrenic, organic, and affective psychoses. Proc Annu Meet Am Psychopathol Assoc. 1966;54:49-62.
63. Delespaul P, deVries M, van Os J. Determinants of occurrence and recovery from hallucinations in daily life. Soc Psychiatry Psychiatr Epidemiol. 2002;37:97-104.
64. Gauntlett-Gilbert J, Kuipers E. Phenomenology of visual hallucinations in psychiatric conditions. J Nerv Ment Dis. 2003;191:203-205.
65. Kelleher I, Harley M, Murtagh A, Cannon M. Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull. 2011;37:362-369.
66. Deahl MP. Do patients see visions that talk? Lancet. 1987;1:812.
67. Fenelon G. Hallucinations in Parkinson's disease. In: Laroi FA, Aleman A, eds. Hallucinations: A Guide to Treatment and Management. Oxford: Oxford University Press; 2010.
68. Ballard C, Saad K, Patel A, et al. The prevalence and phenomenology of psychotic symptoms in dementia sufferers. Int J Geriatr Psychiatry. 1995;19:477-483.
69. Mosimann U, Collerton D. Hallucinations in the context of dementing illnesses. In: Frank Laroi AA, ed. Hallucinations: A Guide to Treatment and Management. 1st ed. Oxford: OUP; 2010.
70. Dudley R, Wood M, Spencer H, Brabban A, Mosimann UP, Collerton D. Identifying specifc interpretations and use of safety behaviours in people with distressing visual hallucinations: an exploratory study. Behav Cogn Psychother. 2012;40:367-375.
71. Rosenthal D, Quinn OW. Quadruplet hallucinations. Phenotypic variations of a schizophrenic genotype. Arch Gen Psychiatry. 1977;34:817-827.
72. Asaad G, Shapiro B. Hallucinations: theoretical and clinical overview. Am J Psychiatry. 1986;143:1088-1097.
73. Chapman LJ, Edell WS, Chapman J P. Physical anhedonia, perceptual aberration, and psychosis proneness. Schizophr Bull. 1980;6:639-653.
74. Johns L, Kompus K, Connell M, et al. Auditory verbal hallucinations in persons with and without a need for care. Schizophr Bull. 2014;40:S255-S264.
75. Ffytche DH. Visual hallucinations and the Charles Bonnet syndrome. Curr Psychiatry Rep. 2005;7:168-179.
76. Eperjesi F. Visual hallucinations in Charles Bonnet syndrome. In: Aleman FLA, ed. Hallucinations: A Guide to Treatment and Management. Oxford: Oxford University Press; 2010.
77. Ffytche DH. Visual hallucinatory syndromes: past, present, and future. Dialogues Clin Neurosci. 2007;9:173-189.
78. Aleman A, Laroi F. Hallucinations: The Science of Idiosyncratic Perception. Washington, DC: American Psychological Association; 2008.
79. Blom JD. A Dictionary of Hallucinations. New York, NY: Springer Science + Business Media; 2010.
80. Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel Perception and Attention Defcit model for recurrent complex visual hallucinations. Behav Brain Sci. 2005;28:737-757; discussion 757-794.
81. Diederich NJ, Fénelon G, Stebbins G, Goetz CG. Hallucinations in Parkinson disease. Nat Rev Neurol. 2009;5:331-342.
82. Shine JM, Halliday GM, Naismith SL, Lewis SJ. Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks? Mov Disord. 2011;26:2154-2159.
83. Bentall RP, Baker GA, Havers S. Reality monitoring and psychotic hallucinations. Br J Clin Psychol. 1991;30 (Pt 3):213-222.
84. Brébion G, Ohlsen RI, Pilowsky LS, David AS. Visual hallucinations in schizophrenia: confusion between imagination and perception. Neuropsychology. 2008;22:383-389.
85. Waters F, Woodward T, Allen P, Aleman A, Sommer I. Self-recognition defcits in schizophrenia patients with auditory hallucinations: a meta-analysis of the literature. Schizophr Bull. 2012;38:741-750.
86. Jardri R, Thomas P, Delmaire C, Delion P, Pins D. The neu-rodynamic organization of modality-dependent hallucinations. Cereb Cortex. 2013;23:1108-1117.
87. Oertel V, Rotarska-Jagiela A, van de Ven VG, Haenschel C, Maurer K, Linden DE. Visual hallucinations in schizophrenia investigated with functional magnetic resonance imaging. Psychiatry Res. 2007;156:269-273.
88. Silbersweig D, Stern E. Functional neuroimaging of hallucinations in schizophrenia: toward an integration of bottom-up and top-down approaches. Mol Psychiatry. 1996;1:367-375.
89. Holroyd S, Shepherd ML, Downs JH 3rd. Occipital atrophy is associated with visual hallucinations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2000;12:25-28.
90. O'Brien JT, Colloby SJ, Pakrasi S, et al. Nicotinic alpha-4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. Neuroimage. 2008;40:1056-1063.
91. Taylor JP, Firbank MJ, He J, et al. Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. Br J Psychiatry. 2012;200:491-498.
92. Ffytche DH, Howard RJ, Brammer MJ, David A, Woodruff P, Williams S. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci. 1998;1:738-742.
93. Diederich NJ, Fénelon G, Stebbins G, Goetz CG. Hallucinations in Parkinson disease. Nat Rev Neurol. 2009;5:331-342.
94. Holroyd S, Wooten GF. Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations. J Neuropsychiatry Clin Neurosci. 2006;18:402-404.
95. Stebbins GT, Goetz CG, Carrillo MC. Altered cortical visual processing in PD with hallucinations: an fMRI study. 2004;63:1409-1416.
96. Goldman JG, Stebbins GT, Dinh V, et al. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations. Brain. 2014;137(Pt3):849-859.
97. Amad A, Cachia A, Gorwood P, et al. The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations. Mol Psychiatry. 2014;19:184-191.
98. Ashtari M, Cottone J, Ardekani BA, et al. Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fber tractog-raphy. Arch Gen Psychiatry. 2007;64:1270-1280.
99. Ibarretxe-Bilbao N, Ramírez-Ruiz B, Tolosa E, et al. Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. J Neurol. 2008;255:1324-1331.
100. Behrendt RP. Contribution of hippocampal region CA3 to consciousness and schizophrenic hallucinations. Neurosci Biobehav Rev. 2010;34:1121-1136.
101. Allen P, Modinos G, Hubl D, et al. Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neu-rochemistry and beyond. Schizophr Bull. 2012;38:695-703.
102. Spencer KM, Nestor PG, Perlmutter R, et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A. 2004;101:17288-17293.
103. Matsui H, Udaka F, Tamura A, et al. The relation between visual hallucinations and visual evoked potential in Parkinson disease. Clin Neuropharmacol. 2005;28:79-82.
104. Abraham HD, Duffy FH. EEG coherence in post-LSD visual hallucinations. Psychiatry Res. 2001;107:151-163.
105. Ffytche DH. The hodology of hallucinations. Cortex. 2008;44:1067-1083.
106. Kazui H, Ishii R, Yoshida T. Neuroimaging studies in patients with Charles Bonnet syndrome. Psychogeriatrics 2009;9:77-84.
107. O'Brien P, Johns L. A graded exposure intervention for distressing visual hallucinations in schizophrenia. Behav Cogn Psychother. 2013;3:45-46.
108. Gauntlett-Gilbert J, Kuipers E. Visual hallucinations in psychiatric conditions: appraisals and their relationship to distress. Br J Clin Psychol. 2005;44:77-87.
109. Collerton D, Dudley R. A cognitive behavioural framework for the treatment of distressing visual hallucinations in older people. Behav Cogn Psychother. 2004;32:443-455.
110. Cuesta MJ, Peralta V, Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res. 2001;48:17-28.
111. The Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med. 1999;340:757-763.
112. Singh A, Sørensen TL. Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration. Br J Ophthalmol. 2011;95:291-292.
113. Pinto T, Lanctôt KL, Herrmann N. Revisiting the cholin-ergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type. Ageing Res Rev. 2011;10:404-412.
114. Patel SS, Attard A, Jacobsen P, Shergill S. Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report. BMC Psychiatry. 2010;10:68.